Fleck Leonard M
Camb Q Healthc Ethics. 2018 Apr;27(2):271-283. doi: 10.1017/S0963180117000603.
Meeting healthcare needs is a matter of social justice. Healthcare needs are virtually limitless; however, resources, such as money, for meeting those needs, are limited. How then should we (just and caring citizens and policymakers in such a society) decide which needs must be met as a matter of justice with those limited resources? One reasonable response would be that we should use cost effectiveness as our primary criterion for making those choices. This article argues instead that cost-effectiveness considerations must be constrained by considerations of healthcare justice. The goal of this article will be to provide a preliminary account of how we might distinguish just from unjust or insufficiently just applications of cost-effectiveness analysis to some healthcare rationing problems; specifically, problems related to extraordinarily expensive targeted cancer therapies. Unconstrained compassionate appeals for resources for the medically least well-off cancer patients will be neither just nor cost effective.
满足医疗保健需求是一个社会正义问题。医疗保健需求几乎是无限的;然而,用于满足这些需求的资源,比如资金,却是有限的。那么,我们(这样一个社会中公正且富有同情心的公民和政策制定者)应该如何决定,在这些有限的资源下,哪些需求必须作为正义问题得到满足呢?一个合理的回应可能是,我们应该将成本效益作为做出这些选择的主要标准。然而,本文认为,成本效益考量必须受到医疗保健正义考量的约束。本文的目标将是初步阐述,我们如何区分成本效益分析在某些医疗资源分配问题上的公正应用与不公正或不够公正的应用;具体而言,是与极其昂贵的靶向癌症治疗相关的问题。无限制地出于同情为医疗状况最差的癌症患者呼吁资源,既不公正也不具有成本效益。